Getting long-term oxygen therapy right
The Lancet Global Health, vol. 13, pp. e983–e985
Abstract
[Extract] The Lancet Global Health Commission on medical oxygen security makes huge strides in advancing our understanding of this global issue. 1 However, it does not address long-term oxygen therapy (LTOT) security for exertional and resting hypoxaemia. LTOT is cost-effective, improves quality of life and functional status among individuals with severe exertional hypoxaemia from chronic respiratory diseases such as interstitial lung disease, and reduces mortality in those with chronic severe resting hypoxaemia from chronic obstructive pulmonary disease (COPD). 2 Hence, in addition to the Commission's recommendations, we urge global health organisations, governments, health systems, clinicians, and advocacy groups to address key areas related to LTOT in future oxygen security efforts ( figure ). Key areas include development of data collection platforms, defining judicious use of existing LTOT resources, improving infrastructure to achieve equity in access, investing in new technologies, and accelerating global efforts to reduce chronic hypoxaemia burden.
Authors 6
-
Universidad del Desarrollo · Clínica Alemana
Affiliation as printed
Departamento de Neumología, Clínica Alemana de Santiago, Universidad del Desarrollo, Santiago, Chile
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Department of Pneumology and Intensive Care Medicine, University Hospital RWTH Aachen, Aachen, Germany
-
Affiliation as printed
College of Health Sciences, James Cook University Division of Tropical Health and Medicine, Townsville, QLD, Australia
-
Affiliation as printed
Faculty of Medicine, University of Melbourne, Melbourne, VIC, Australia
-
Affiliation as printed
International Primary Care Respiratory Group, Edinburgh, UK
-
Neelima Navuluri corresponding
Affiliation as printed
Department of Medicine, Duke University, Durham, NC, USA; Duke Global Health Institute, Durham, NC, USA. Electronic address: neelima.navuluri@duke.edu
Cited by 1 stored of 1
1 result
No patents citing this paper on Lens.org (checked 2026-10-06).
References 9
9 results